ID: ALA4238859

Max Phase: Preclinical

Molecular Formula: C5H9N3O2

Molecular Weight: 143.15

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  NNC(=O)[C@@H]1CCC(=O)N1

Standard InChI:  InChI=1S/C5H9N3O2/c6-8-5(10)3-1-2-4(9)7-3/h3H,1-2,6H2,(H,7,9)(H,8,10)/t3-/m0/s1

Standard InChI Key:  UVODKQNEOJXKPD-VKHMYHEASA-N

Associated Targets(non-human)

Bacillus thuringiensis 718 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 143.15Molecular Weight (Monoisotopic): 143.0695AlogP: -1.75#Rotatable Bonds: 1
Polar Surface Area: 84.22Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.30CX Basic pKa: 2.83CX LogP: -1.99CX LogD: -1.99
Aromatic Rings: 0Heavy Atoms: 10QED Weighted: 0.23Np Likeness Score: -0.53

References

1. Gang FL, Zhu F, Li XT, Wei JL, Wu WJ, Zhang JW..  (2018)  Synthesis and bioactivities evaluation of l-pyroglutamic acid analogues from natural product lead.,  26  (16): [PMID:30119995] [10.1016/j.bmc.2018.07.041]

Source